Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 1961-1962, 2004; 10.1373/clinchem.2004.040758
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de la Torre, R.
Right arrow Articles by Pichini, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de la Torre, R.
Right arrow Articles by Pichini, S.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Drug Monitoring and Toxicology
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:1961-1962.)
© 2004 American Association for Clinical Chemistry, Inc.

Editorials

Usefulness of Sweat Testing for the Detection of Cannabis Smoke

Rafael de la Torre1,2,a and Simona Pichini3

1 Institut Municipal d’Investigació Mèdica (IMIM), and 2 Universitat Pompeu Fabra, Barcelona, Spain
3 Drug Research and Control Department, Istituto Superiore di Sanità, Rome, Italy

aAddress correspondence to this author at: Institut Municipal d’Investigació Mèdica (IMIM), Doctor Aiguader 80, E-08003 Barcelona, Spain. Fax 34-932213237; e-mail rtorre@imim.es.

The first 20% of the full text of this article appears below.

Several reports have demonstrated that sweat is a suitable alternative biological matrix for monitoring recent drug use (1)(2). This is based on the assumption that, in the context of the absorption/distribution/metabolism/excretion (ADME) cycle of drugs, a small but sufficient fraction of a drug is excreted in sweat and can be tested. The passage of lipid-soluble compounds from blood to other fluids or matrices is regulated by the substance’s pKa and by the pH of the other fluids or matices. A modified version of the Henderson–Hasselbach equation, which uses the pKa and the pH, allows theoretical calculation of the fluid-to-plasma concentration ratio (F/P ratio) (3). Drugs are generally incorporated into sweat by passive diffusion because of a concentration gradient in which only the free fraction of drug (unbound to proteins) diffuses through lipid membranes from plasma to sweat. Furthermore, because under normal conditions sweat, with a mean pH of 6.3, is more acidic than blood, basic drugs tend to accumulate in sweat.

Two approaches are currently used in testing for drugs in sweat. The first is aimed at detection of recent use of drugs (<24 h) and involves only collection of sweat at a point in time. An immunochromatographic test of the sample then provides a qualitative result (4), or drugs in sweat collected on a cotton wipe can be extracted and subjected to confirmatory analysis (5). This approach is mainly oriented to identify individuals who are under the influence of drugs. The second approach is based on patch technology and allows monitoring of illicit drug use for time windows wider than those provided by urine . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.